We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
iRobot (IRBT) Stock Slips, Should You Buy The Dip?
Read MoreHide Full Article
Shares of iRobot Corporation (IRBT - Free Report) sank 7.28% on Wednesday thanks to a significant analyst downgrade.
Wealth management and investment banking firm Canaccord Genuity downgraded iRobot’s stock from a “buy” to a “hold” in a note to clients this morning. The firm gave the company a $90 price target, which marks a significant decline.
While Canaccord Genuity remains relatively positive on iRobot's long-term outlook, the firm feels that without a new product to help boost 2017 sales, the company might be hurt during the all-important holiday season.
The maker of Roomba autonomous robot vacuum cleaners, as well as similar floor mop and pool cleaner versions, had received almost nothing but praise this year until this point. Even with today’s big dip, the company is only slightly off its 52-week and all-time high of $99.98 per share.
Positive Outlook
Still, Canaccord Genuity’s assessment might be an outlier at the moment, as iRobot is currently a Zacks Rank #1 (Strong Buy). The company recently posted massive first-quarter beats for both earnings and revenue, and at beginning of the current quarter, iRobot completed the purchase of its Japanese distributor. The company’s updated full-year guidance has helped lead to a flurry of earnings estimate revision activity for both 2017 and 2018.
Furthermore, our current full-year Zacks Consensus Estimate calls for annual sales growth of 19.04% this year, which is far above the industry average of 9.49%. This helped the in-home robot company score an “A” for Growth in our Zacks Style Score system.
Shares of iRobot over the last three months have yielded a return of 67.25%, which outperformed the average Zacks Industrial Automation and Robotics industry growth rate of 6.22%. On top of that, Industrial Automation and Robotics industry currently sits in the Top 9% of the Zacks Industry Rank.
iRobot has been on an insane run, and today’s dip could indicate that investors wanted the stock to pull back a little, but it could also provide a discounted buying opportunity.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade, which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
iRobot (IRBT) Stock Slips, Should You Buy The Dip?
Shares of iRobot Corporation (IRBT - Free Report) sank 7.28% on Wednesday thanks to a significant analyst downgrade.
Wealth management and investment banking firm Canaccord Genuity downgraded iRobot’s stock from a “buy” to a “hold” in a note to clients this morning. The firm gave the company a $90 price target, which marks a significant decline.
While Canaccord Genuity remains relatively positive on iRobot's long-term outlook, the firm feels that without a new product to help boost 2017 sales, the company might be hurt during the all-important holiday season.
The maker of Roomba autonomous robot vacuum cleaners, as well as similar floor mop and pool cleaner versions, had received almost nothing but praise this year until this point. Even with today’s big dip, the company is only slightly off its 52-week and all-time high of $99.98 per share.
Positive Outlook
Still, Canaccord Genuity’s assessment might be an outlier at the moment, as iRobot is currently a Zacks Rank #1 (Strong Buy). The company recently posted massive first-quarter beats for both earnings and revenue, and at beginning of the current quarter, iRobot completed the purchase of its Japanese distributor. The company’s updated full-year guidance has helped lead to a flurry of earnings estimate revision activity for both 2017 and 2018.
Furthermore, our current full-year Zacks Consensus Estimate calls for annual sales growth of 19.04% this year, which is far above the industry average of 9.49%. This helped the in-home robot company score an “A” for Growth in our Zacks Style Score system.
Shares of iRobot over the last three months have yielded a return of 67.25%, which outperformed the average Zacks Industrial Automation and Robotics industry growth rate of 6.22%. On top of that, Industrial Automation and Robotics industry currently sits in the Top 9% of the Zacks Industry Rank.
iRobot has been on an insane run, and today’s dip could indicate that investors wanted the stock to pull back a little, but it could also provide a discounted buying opportunity.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade, which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>